• YTHDF2, m6A Decay, and Hippocampal Memory

  2026-09-10

  A 2025 Advanced Science study identifies YTHDF2-mediated degradation of m6A-marked mRNAs as a causal regulator of hippocampus-dependent learning and memory. Forebrain YTHDF2 loss increased synaptic transmission and activity-dependent protein synthesis, while YTHDF2 restoration or SEMA4B reduction reversed the memory enhancement, providing a mechanistic framework for studying RNA regulation in neural plasticity.

• Recombinant Mouse M-CSF: Assay Workflows

  2026-09-10

  Build more consistent macrophage cultures, osteoclast progenitor assays, and fibrosis-focused experiments with a tag-free mouse cytokine. This guide connects practical M-CSF handling with the IGF2BP1–THBS1–TLR4 findings reported in pulmonary fibrosis research.

• Bestatin (Ubenimex): Applied Research Workflows

  2026-09-09

  Bestatin (Ubenimex) combines a defined aminopeptidase selectivity profile with practical utility in enzyme assays, multidrug resistance research, and apoptosis workflows. This guide translates structural evidence into reproducible preparation, dosing, controls, and troubleshooting strategies.

• Parthenolide, ROS, and Apoptosis in Lymphoid Malignancies

  2026-09-09

  Jorge and colleagues show that parthenolide reduces metabolic activity and promotes oxidative-stress-associated apoptosis across diverse B- and T-lineage lymphoid malignancy models. The study is valuable because it connects a resazurin-based viability readout with mitochondrial, redox, apoptotic, NF-κB, and gene-expression measurements, while also demonstrating strong cell-line-dependent responses.

• Curcumin, NLRP3, and Endothelial Pyroptosis

  2026-09-08

  The reference study shows that curcumin protects human umbilical vein endothelial cells from H2O2-induced injury by suppressing NLRP3-associated pyroptosis and improving endothelial functional markers. Its use of caspase-1 and NLRP3 inhibitors strengthens the mechanistic interpretation, while the model provides a useful framework for studying oxidative endothelial dysfunction relevant to atherosclerosis.

• Tetrazolium (chloride) for Viability Assays

  2026-09-07

  Tetrazolium (chloride), also called Tetrazolium Red, converts reductive enzyme activity into a visible formazan signal for cell and tissue analysis. This guide shows how to pair quantitative cell assays with ischemic brain staining, interpret mitochondrial readouts, and troubleshoot weak or misleading color development.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-09-07

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that may separate poorly with conventional Tris-SDS-PAGE. It is suitable for controlled research workflows, including denaturing and non-denaturing electrophoresis, but is not intended for diagnostic, clinical, or medical use.

• CLK2 and Platinum Resistance in Ovarian Cancer

  2026-09-05

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a clinically relevant mediator of platinum resistance in ovarian cancer and links this effect to BRCA1 phosphorylation at Ser1423. Its integrated tissue, cellular, mechanistic, and xenograft evidence supports CLK2 as a candidate target for studying DNA damage repair and treatment response.

• Necrosulfonamide Workflow for MLKL Necroptosis Assays

  2026-09-04

  Necrosulfonamide provides a pathway-focused way to test whether MLKL membrane translocation drives injury after oxidative, hypoxic, or inflammatory stress. This practical guide connects NSA dosing, membrane-integrity readouts, and the cardiac microvascular findings of a 2025 reference study to more interpretable necroptosis assays.

• Protoporphyrin IX at the Heme–Ferroptosis Nexus

  2026-09-04

  A translational framework for using Protoporphyrin IX as a photodynamic compound and heme-pathway probe while investigating iron-dependent ferroptosis in hepatocellular carcinoma.

• ICAA, HO-1, and HBV Replication: Mechanistic Insights

  2026-09-04

  The reference study shows that isochlorogenic acid A (ICAA) suppresses hepatitis B virus replication at multiple stages, including transcription, cccDNA maintenance, capsid formation, and envelopment. Its findings connect HO-1-associated reactive oxygen species modulation with altered viral structural-protein chemistry, providing a mechanistic framework for studying host-directed antiviral effects.

• Naloxone Hydrochloride: A Mechanism-First Guide

  2026-09-03

  Naloxone hydrochloride is more than a standard opioid receptor antagonist: it is a powerful tool for separating receptor-mediated signaling from receptor-independent cellular effects. This mechanism-first guide connects opioid, neural, and immune assays with practical lessons from modern inhibitor-discovery research.

• N4-Acetylcytidine: From Structure to Translation

  2026-09-02

  N4-Acetylcytidine is more than a modified nucleoside standard. Recent structural work separates free ac4C metabolism from RNA-embedded modification biology, providing a sharper framework for enzyme assays, RNA structure-function analysis, reagent selection, and translational interpretation.

• ICG001 for Reliable Wnt Assays

  2026-09-02

  Learn how ICG001 (SKU A8217) can improve interpretation of cell viability, proliferation, and cytotoxicity experiments involving Wnt/β-catenin signaling. This scenario-based guide covers mechanism, assay design, dosing, controls, compound handling, and vendor-selection criteria.

• TG003 and the Translational Logic of CLK2 Biology

  2026-09-01

  TG003 offers a reversible pharmacological route to interrogate Cdc2-like kinase biology, alternative splicing, and the CLK2–BRCA1 axis implicated in platinum resistance. This thought-leadership analysis connects splice-factor phosphorylation with translational study design while distinguishing validated evidence from forward-looking hypotheses.

8037 records 1/536 page Next 12345 下5页 Last page